When was Acclarent founded?

Acclarent was founded in 2004 and raised its 1st funding round 1 year after it was founded.

Where is Acclarent located?

Acclarent is headquartered in Irvine, United States. It is registered at 33 Technology Dr, Irvine, CA 92618, United States.

How many employees does Acclarent have?

As of Sep 30, 2026, the latest employee count at Acclarent is 172.

Is Acclarent a funded company?

Acclarent is a funded company, having raised a total of $61M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Dec 27, 2005.

When was the latest funding round of Acclarent?

Acclarent's latest funding was a $***** Series D round on Jan 12, 2009, with participation from 5 investors. Its primary sector is ENT Disorders. In United States, the ENT Disorders sector has seen $267M in funding in 2026 to date.

Where does Acclarent rank among its competitors?

Acclarent ranks 5th amongst 11 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Tivic Health, which secured $28.3M in Dec, 2025.

Who are the top competitors of Acclarent?

Acclarent's top competitors include Intersect ENT, Tivic Health and Entellus Medical. Among them, Tivic Health secured the most recent funding round in December, 2025.

Acclarent - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a balloon-based sinuplasty technology. The company is dedicated to supporting Ear, Nose, and Throat surgeons with minimally invasive technologies designed to preserve nasal anatomy, while addressing rhinosinusitis and persistent Eustachian Tube Dysfunction.

Website: acclarent.com
Part Of
Registered Address: 33 Technology Dr, Irvine, CA 92618, United States

Key Metrics

Founded Year

2004

Location

Irvine, United States

Stage

Acquired

Total Funding

$61M in 3 rounds

Latest Funding Round

Series D, Jan 12, 2009, $*****

Investors

Meritech & 5 more

Ranked

5^th among 11 active competitors

Employee Count

172 as on Sep 30, 2026

Similar Companies

Intersect ENT & 12 more

Exit Details

Acquired by Integra LifeSciences (Dec 13, 2023)

View Acclarent's full profile

Acclarent is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Acclarent, Inc CIN: 201772549 , United States, Active	Jun 06, 2004	-	349 (As on Dec 31, 2011)	-

Acclarent got acquired by Integra LifeSciences on Dec 13, 2023 at an acquisition amount of $*****.

Click here to take a look at Acclarent's acquisition in detail

Acclarent has raised a total funding of $61M over 3 rounds. Its first funding round was on Dec 27, 2005. Its latest funding round was a Series D round on Jan 12, 2009 for $*****. 5 investors participated in its latest round. Acclarent has 6 institutional investors.

Here is the list of recent funding rounds of Acclarent:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 12, 2009	3853150	Series D	8403934	5379230	2568148	2527816
Apr 23, 2007	5458834	Series C	3780584	2443890	6212001	Delphi Ventures & 2 more
Dec 27, 2005	4972596	Series B	5488890	6045577	3215794	8979245

Access funding benchmarks and valuations. Sign up today!

View details of Acclarent's funding rounds and investors

The founders of Acclarent are Joshua Makower and John Chang.

Here are the details of Acclarent's key team members:

Joshua Makower: Co-Founder & Chairman of Acclarent and founder of 1 other company. They serve on the boards of 2 companies.
John Chang: Co-Founder & VP of Acclarent and founder of 1 other company.
Contact Info: 1 email address

View details of Acclarent's Founder profiles and Board Members

Acclarent's employee count trend

Acclarent has 172 employees as of Sep 26. Here is Acclarent's employee count trend over the years:

Uncover Acclarent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Acclarent include Intersect ENT, Tivic Health and Entellus Medical. Here is the list of Top 10 competitors of Acclarent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Intersect ENT 2003, Menlo Park (United States), Acquired	Developer of drug releasing implant to treat sinusitis	$76.5M	Medtronic, Norwest & 13 others	52/100
2nd	Tivic Health 2016, Menlo Park (United States), Public	Developer of a bioelectronic medical device for the treatment of sinusitis	$8M	HBS Alumni Angels Association, Lateral Frontiers ... & 14 others	48/100
3rd	Entellus Medical 2006, Plymouth (United States), Acquired	Developer of suite of products for treating chronic sinusitis	$90.5M	Greenspring Associates, EW Healthcare Partners ... & 4 others	48/100
4th	MyPurMist 2001, Concord (United States), Seed	Natural steam inhalers and air purifiers for respiratory relief	$8.89M	Band of Angels, Keiretsu Forum & 2 others	45/100
5th	Acclarent 2004, Irvine (United States), Acquired	Developer of a balloon-based sinuplasty technology	$61M	Meritech, Versant Ventures & 4 others	44/100
6th	Dalent Medical 2017, Coral Gables (United States), Seed	Developer of balloon-based sinus dilation device	$3.45M	Miami Angels, Verve Capital & 3 others	40/100
7th	Jeder System 2010, Vienna (Austria), Acquired	Minimally invasive sinus lift system	$1.22M	Austria Wirtschaftsservice, tecnet equity ... & 1 others	30/100
8th	Sinusafe Medical 2015, Kiryat Ono (Israel), Funding Raised	Medical device for sinus lavage	-	Incentive Incubator, Peregrine Ventures	26/100
9th	SinuSys 2010, Palo Alto (United States), Series D	Sinus Dilation Made Simple	-	Emergent Medical Partners, AshHill	25/100
10th	MediSinus 2006, Tel Aviv (Israel), Deadpooled	Medical device for the treatment of sinusitis	-	-	23/100